Testosterone and cardioprotection against myocardial ischemia

Cardiovascular and Hematological Disorders - Drug Targets

Volumn 7, Issue 2, 2007, Pages 119-125

  Tsang, Sharon ^a   Liu, Jing ^a   Wong, Tak Ming ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Adrenoceptor; Calcium homeostasis; Myocardial ischemia; Testosterone

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; ALPHA 1 ADRENERGIC RECEPTOR; ANDROSTANOLONE; BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM; CALCIUM CHANNEL L TYPE; ESTROGEN; HEAT SHOCK PROTEIN 70; HEAT SHOCK TRANSCRIPTION FACTOR 1; NORADRENALIN; PROTEIN KINASE B; SOMATOMEDIN C; TESTOSTERONE;

ALPHA ADRENERGIC STIMULATION; CALCIUM HOMEOSTASIS; CONCENTRATION RESPONSE; DRUG MECHANISM; GENDER; HEART CONTRACTION; HEART INFARCTION PREVENTION; HEART MITOCHONDRION; HEART MUSCLE CELL; HEART MUSCLE FIBER MEMBRANE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; HORMONE ACTION; HORMONE SUBSTITUTION; HUMAN; METABOLIC INHIBITION; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; REPERFUSION INJURY; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION; VASODILATATION;

EID: 34347391936     PISSN: 1871529X     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152907780830888     Document Type: Review

References (111)

1. Murray, C.J.L.; Lopez, A.D. The global burden of diseases. Geneva: World Health Organization. 1996.
2. Opie, L.H. The mechanism of myocyte death in ischaemia. Eur. Heart J., 1993, 14(Suppl G), 31-3.
3. Karlsberg, R.P.; Cryer, P.E.; Roberts, R. Serial plasma catecholamine response early in the course of clinical acute myocardial infarction: relationship to infarct extent and mortality. Am. Heart J., 1981, 102(1), 24-9.
4. Schomig, A. Catecholamines in myocardial ischemia. Systemic and cardiac release. Circulation, 1990, 82(3 Suppl), II13-22.
5. Schomig, A.; Richardt, G. The role of catecholamines in ischemia. J. Cardio. Pharmacol., 1990, 16(Suppl. 5), S105-12.
6. Schomig, A.; Richardt, G. Cardiac sympathetic activity in myocardial ischemia: release and effects of noradrenaline. Basic Res. Cardiol., 1990, 85(Suppl 1), 9-30.
7. Suleiman, M.S.; Halestrap, A.P.; Griffiths, E.J. Mitochondria: a target for myocardial protection. Pharmacol. Ther., 2001, 89(1), 29-46.
8. Kalin, M.F.; Zumoff, B. Sex hormones and coronary disease: a review of the clinical studies. Steroids, 1990, 55(8), 330-52.
9. Stamler, J. Lectures on preventive cardiology. Grune and Stratton, New York, 1967; pp. 95.
10. Eaker, E.D.; Chesebro, J.H.; Sacks, F.M.; Wenger, N.K.; Whisnant, J.P.; Winston, M. Cardiovascular disease in women. Circulation, 1993, 88(4 Pt 1), 1999-2009.
11. Lerner, D.J.; Kannel, W.B. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am. Heart J., 1986, 111(2), 383-90.
12. Collins, P.; Rosano, G.M.; Jiang, C.; Lindsay, D.; Sarrel, P.M.; Poole-Wilson, P.A. Cardiovascular protection by oestrogen - a calcium antagonist effect? Lancet, 1993, 341(8855), 1264-5.
13. Kam, K.W.; Qi, J.S.; Chen, M.; Wong, T.M. Estrogen reduces cardiac injury and expression of beta1-adrenoceptor upon ischemic insult in the rat heart. J. Pharmacol. Exp. Ther., 2004, 309(1), 8-15.
14. Kam, K.W.; Kravtsov, G.M.; Liu, J.; Wong, T.M. Increased PKA activity and its influence on isoprenaline-stimulated L-type Ca2+ channels in the heart from ovariectomized rats. Br. J. Pharmacol., 2005, 144(7), 972-81.
15. Delyani, J.A.; Murohara, T.; Nossuli, T.O.; Lefer, A.M. Protection from myocardial reperfusion injury by acute administration of 17 beta-estradiol. J. Mol. Cell Cardiol., 1996, 28(5), 1001-8.
16. Bush, T.L.; Barrett-Connor, E.; Cowan, L.D.; Criqui, M.H.; Wallace, R.B.; Suchindran, C.M.; Tyroler, H.A.; Rifkind, B.M. Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation, 1987, 75(6), 1102-9.
17. Mendelsohn, M.E. Nongenomic, ER-mediated activation of endothelial nitric oxide synthase: how does it work? What does it mean? Circ. Res., 2000, 87(11), 956-60.
18. Mendelsohn, M.E. Mechanisms of estrogen action in the cardiovascular system. J. Steroid. Biochem. Mol. Biol., 2000, 74(5), 337-43.
19. Dickerman, R.D.; Schaller, F.; Prather, I.; McConathy, W.J. Sudden cardiac death in a 20-year-old bodybuilder using anabolic steroids. Cardiology, 1995, 86(2), 172-3.
20. Adams, M.R.; Williams, J.K.; Kaplan, J.R. Effects of androgens on coronary artery atherosclerosis and atherosclerosis-related impairment of vascular responsiveness. Arterio. Thromb. Vasc. Biol., 1995, 15(5), 562-70.
21. Melchert, R.B.; Welder, A.A. Cardiovascular effects of androgenic-anabolic steroids. Med. Sci. Sports Exerc., 1995, 27(9), 1252-62.
22. Ferrera, P.C.; Putnam, D.L.; Verdile, V.P. Anabolic steroid use as the possible precipitant of dilated cardiomyopathy. Cardiology, 1997, 88(2), 218-20.
23. Sullivan, M.L.; Martinez, C.M.; Gennis, P.; Gallagher, E.J. The cardiac toxicity of anabolic steroids. Prog. Cardiovasc. Dis., 1998, 41(1), 1-15.
24. Zaugg, M.; Jamali, N.Z.; Lucchinetti, E.; Xu, W.; Alam, M.; Shafiq, S.A.; Siddiqui, M.A. Anabolic-androgenic steroids induce apoptotic cell death in adult rat ventricular myocytes. J. Cell Physiol., 2001, 187(1), 90-5.
25. Wang, M.; Baker, L.; Tsai, B.M.; Meldrum, K.K.; Meldrum, D.R. Sex differences in the myocardial inflammatory response to ischemia-reperfusion injury. Am. J. Physiol. Endocrinol. Metab., 2005, 288(2), E321-6.
26. Cavasin, M.A.; Tao, Z.Y.; Yu, A.L.; Yang, X.P. Testosterone enhances early cardiac remodeling after myocardial infarction, causing rupture and degrading cardiac function. Am. J. Physiol. Heart Circ. Physiol., 2006, 290(5), H2043-50.
27. Jaffe, M.D. Effect of testosterone cypionate on postexercise ST segment depression. Br. Heart J., 1977, 39(11), 1217-22.
28. Rosano, G.M.; Leonardo, F.; Pagnotta, P.; Pelliccia, F.; Panina, G.; Cerquetani, E.; della, Monica, P.L.; Bonfigli, B.; Volpe, M.; Chierchia, S.L. Acute anti-ischemic effect of testosterone in men with coronary artery disease. Circulation, 1999, 99(13), 1666-70.
29. English, K.M.; Mandour, O.; Steeds, R.P.; Diver, M.J.; Jones, T.H.; Channer, K.S. Men with coronary artery disease have lower levels of androgens than men with normal coronary angiograms. Eur. Heart J., 2000, 21(11), 890-4.
30. English, K.M.; Jones, R.D.; Jones, T.H.; Morice, A.H.; Channer, K.S. Aging reduces the responsiveness of coronary arteries from male Wistar rats to the vasodilatory action of testosterone. Clin. Sci. (Lond.), 2000, 99(1), 77-82.
31. English, K.M.; Steeds, R.P.; Jones, T.H.; Diver, M.J.; Channer, K.S. Low dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina. Circulation, 2000, 102, 1906-1911.
32. Wu, S.Z.; Weng, X.Z. Therapeutic effects of an androgenic preparation on myocardial ischemia and cardiac function in 62 elderly male coronary heart disease patients. Chin, Med. J. (Engl.), 1993, 106, 415-418.
33. Webb, C.M.; Adamson, D.L.; de Zeigler, D and Collins, P. Effect of acute testosterone on myocardial ischemia in men with coronary artery disease. Am. J. Cardiol., 1999, 83, 437-439, A439.
34. Webb, C.M.; McNeill, J.G.; Hayward, C.S, de Zeigler, D and Collins, P. Effects of testosterone on coronary vasomotor regulation in men with coronary heart disease. Circulation, 1999, 100, 1690-1696.
35. Thompson, P.D.; Zimet, R.; Forbes, W.P.; Zhang, P. Meta-analysis of results from eight randomized, placebo-controlled trials on the effect of cilostazol on patients with intermittent claudication. Am. J. Cardiol., 2002, 90(12), 1314-9.
36. Malkin, C.J.; Pugh, P.J.; Morris, P.D.; Kerry, K.E.; Jones, R.D.; Jones, T.H.; Channer, K.S. Testosterone replacement in hypogonadal men with angina improves ischaemic threshold and quality of life. Heart, 2004, 90(8), 871-6.
37. Malkin, C.J.; Pugh, P.J.; Jones, R.D.; Kapoor, D.; Channer, K.S.; Jones, T.H. The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men. J. Clin. Endocrinol. Metab., 2004, 89(7), 3313-8.
38. Malkin, C.J.; Morris, P.D.; Pugh, P.J.; English, K.M.; Channer, K.S. Effect of testosterone therapy on QT dispersion in men with heart failure. Am. J. Cardiol., 2003, 92(10), 1241-3.
39. Malkin, C.J.; Pugh, P.J.; Jones, R.D.; Jones, T.H.; Channer, K.S. Testosterone as a protective factor against atherosclerosis - immunomodulation and influence upon plaque development and stability. J. Endocrinol., 2003, 178(3), 373-80.
40. Thompson, P.D.; Ahlberg, A.W.; Moyna, N.M.; Duncan, B.; Ferraro-Borgida, M.; White, C.M.; McGill, C.C.; Heller, G.V. Effect of intravenous testosterone on myocardial ischemia in men with coronary artery disease. Am. Heart J., 2002, 143(2), 249-56.
41. MacIntyre, K.; Stewart, S.; Capewell, S.; Chalmers, J.W.; Pell, J.P.; Boyd, J.; Finlayson, A.; Redpath, A.; Gilmour, H.; McMurray, J.J. Gender and survival: a population-based study of 201, 114 men and women following a first acute myocardial infarction. J. Am. Coll Cardiol., 2001, 38(3), 729-35.
42. Vaccarino, V.; Krumholz, H.M.; Yarzebski, J.; Gore, J.M.; Goldberg, R.J. Sex differences in 2-year mortality after hospital discharge for myocardial infarction. Ann. Intern. Med., 2001, 134(3), 173-81.
43. Vaccarino, V.; Berkman, L.F.; Krumholz, H.M. Long-term outcome of myocardial infarction in women and men: a population perspective. Am. J. Epidemiol., 2000, 152(10), 965-73.
44. Alexandersen, P.; Haarbo, J.; Christiansen, C. The relationship of natural androgens to coronary heart disease in males: a review. Atheroscl., 1996, 23, 125(1), 1-13.
45. Bonnel, R.W.; Pritchett, C.P.; Rardin, T.E. Treatment of angina pectoris and coronary artery disease with sex hormones. Ohio. State Med. J., 1941, 37, 554-556.
46. Hamm, L. Testosterone propionate in the treatment of angina pectoris. J. Clin. Endocrinol., 1942, 2, 325-328.
47. Lesser, M.A. The treatment of angina pectoris with testosterone propionate: preliminary report. N. Engl. J. Med., 1942, 226, 51-54.
48. Sigler, L.H.; Tulgan, J. Treatment of angina pectoris by testosterone. N. Y. State J. Med., 1943, 43, 1424-1428.
49. Strong, G.F.; Wallace, W. Treatment of angina pectoris and peripheral vascular disease with sex hormones. Can. Med. Assoc. J., 1944, 50, 30-33.
50. Waldman, S. The treatment of angina pectoris with testosterone propionate. J. Clin. Endocrinol., 1945, 5, 305-317.
51. Walker, T.C. The use of testosterone propionate and estrogenic substance in treatment of essential hypertension, angina pectoris and peripheral vascular disease. J. Clin. Endocrinol., 1942, 2, 560-568.
52. Callies, F.; Stromer, H.; Schwinger, H.G.; Bolck, B.; Hu, K.; Frantz, S.; Leupold, A.; Beer, S.; Allolio, B.; Bonz, A.W. Administration of testosterone is associated with a reduced susceptibility to myocardial ischemia. Endocrinology, 2003, 144, 4478-4488.
53. Liu, J.; Tsang, S.; Wong, T.M. Testosterone is required for delayed cardioprotection and enhanced heat shock protein 70 expression induced by preconditioning. Endocrinology, 2006, 147(10), 4569-77.
54. + channels in the cardiac mitochondrial inner membrane. Circulation, 2004, 9, 110(19), 3100-7.
55. Tsang, S.; Wu, S.; Das, R.; Wong, T.M. Testosterone Confers Cardioprotection by up-regulating a1- Adrenoceptors. [Abstract]. J. Mol. Cell Cardiol., 2005, 39, 563.
56. Nahrendorf, M.; Frantz, S.; Hu, K.; von zur Muhlen, C.; Tomaszewski, M.; Scheuermann, H.; Kaiser, R.; Jazbutyte, V.; Beer, S.; Bauer, W.; Neubauer, S.; Ertl, G.; Allolio, B.; Callies, F. Effect of testosterone on post-myocardial infarction remodeling and function. Cardiovasc. Res., 2003, 57(2), 370-8.
57. Seki, S.; MacLeod, K.T. Effects of anoxia on intracellular Ca2+ and contraction in isolated guinea pig cardiac myocytes. Am. J. Physiol., 1995, 268, H1045-52.
58. Hotta, Y.; Fujita, M.; Nakagawa, J.; Ando, H.; Takeya, K.; Ishikawa, N.; Sakakibara, J. Contribution of cytosolic ionic and energetic milieu change to ischemia- and reperfusion-induced injury in guinea pig heart: fluorometry and nuclear magnetic resonance studies. J. Cardiovasc. Pharmacol., 1998, 31(1), 146-56.
59. Kusuoka, H.; Camilion de Hurtado, M.C and Marban, E. Role of sodium/ calcium exchange in the mechanism of myocardial stunning: protective effect of reperfusion with high sodium solution. J. Am. Coll. Cardiol., 1993, 21, 240-248.
60. Zucchi, R.; Ronca, F and Ronca-Testoni, S. Modulation of sarcoplasmic reticulum function: a new strategy in cardioprotection? J. Pharmacol. Ther., 2001, 89, 47-65.
61. Anversa, P.; Cheng, W.; Liu, Y.; Leri, A.; Redaelli, G and Kajstura, J. Apoptosis and myocardial infarction. Basic Res. Cardiol., 1998, 93(Suppl. 3), 8-12.
62. Carrozza, J.P. Jr.; Bentivegna, L.A.; Williams, C.P.; Kuntz, R.E.; Grossman, W.; Morgan, J.P. Decreased myofilament responsiveness in myocardial stunning follows transient calcium overload during ischemia and reperfusion. Circ. Res., 1992, 71(6), 1334-40.
63. Lokuta, A.J.; Meyers, M.B.; Sander, P.R.; Fishman, G.I.; Valdivia, H.H. Modulation of cardiac ryanodine receptors by sorcin. J. Biol. Chem., 1997, 272(40), 25333-8.
64. Michels, G.; Er, F.; Eicks, M.; Herzig, S.; Hoppe, U.C. Long-term and immediate effect of testosterone on single T-type calcium channel in neonatal rat cardiomyocytes. Endocrinology, 2006, 147(11), 5160-9.
65. Er, F.; Michels, G.; Brandt, M.C.; Khan, I.; Haase, H.; Eicks, M.; Lindner, M.; Hoppe, U.C. Impact of testosterone on cardiac L-type calcium channels and Ca(2+) sparks: Acute actions antagonize chronic effects. Cell Calcium, 2006 Epub ahead of print.
66. Golden, K.L.; Marsh, J.D.; Jiang, Y. Testosterone regulates mRNA levels of calcium regulatory proteins in cardiac myocytes. Horm. Metab. Res., 2004, 36, 197-202.
67. Allely, M.C.; Brown, C.M.; Kenny, B.A.; Kilpatrick, A.T.; Martin, A.; Spedding, M. Modulation of alpha 1-adrenoceptors in rat left ventricle by ischaemia and acyl carnitines: protection by ranolazine. J. Cardiovasc. Pharmacol., 1993, 21(6), 869-73.
68. Iwai-Kanai, E.; Hasegawa, K.; Araki, M.; Kakita, T.; Morimoto, T.; Sasayama, S. α- and β-adrenergic pathways differentially regulate cell type-specific apoptosis in rat cardiac myocytes. Circulation, 1999, 100, 305-311.
69. O'Connell, T.D.; Swigart, P.M.; Rodrigo, M.C.; Ishizaka, S.; Joho, S.; Turnbull, L.; Tecott, L.H.; Baker, A.J.; Foster, E.; Grossman, W.; Simpson, P.C. Alpha1-adrenergic receptors prevent a maladaptive cardiac response to pressure overload. J. Clin. Invest., 2006, 116(4), 1005-1015.
70. Communal, C.; Singh, K.; Sawyer, D.B.; Colucci, W.S. Opposing effects of β1- and β2-adrenergic receptors on cardiac myocyte apoptosis Role of pertussis toxin - sensitive G protein. Circulation, 1999, 100, 2210-2212.
71. Communal, C.; Singh, K.; Pimentel, D.R.; Colucci, W.S. Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the β-adrenergic pathway. Circulation, 1998, 98, 1329-1334.
72. Patterson, A.J.; Zhu, W.; Chow, A.; Agrawal, R.; Kosek, J.; Xiao, R.P.; Kobilka, B. Protecting the myocardium: a role for the beta2 adrenergic receptor in the heart. Crit. Care Med., 2004, 32(4), 1041-8.
73. Zhu, W.Z.; Wang, S.Q.; Chakir, K.; Yang, D.; Zhang, T.; Brown, J.H.; Devic, E.; Kobilka, B.K.; Cheng, H.; Xiao, R.P. Linkage of beta1-adrenergic stimulation to apoptotic heart cell death through protein kinase A-independent activation of Ca2+/calmodulin kinase II. J. Clin. Invest., 2003, 111, 617-625.
74. Liu, Y.; Sato, T.; O'Rourke, B.; Marban, E. Mitochondrial ATP-dependent potassium channels: novel effectors of cardioprotection? Circulation, 1998, 97(24), 2463-9.
75. Shake, J.G.; Peck, E.A.; Marban, E.; Gott, V.L.; Johnston, M.V.; Troncoso, J.C.; Redmond, J.M.; Baumgartner, W.A. Pharmacologically induced preconditioning with diazoxide: a novel approach to brain protection. Ann. Thorac. Surg., 2001, 72(6), 1849-54.
76. Garlid, K.D.; Dos Santos, P.; Xie, Z.J.; Costa, A.D.; Paucek, P. Mitochondrial potassium transport: the role of the mitochondrial ATP-sensitive K(+) channel in cardiac function and cardioprotection. Biochim. Biophys. Acta., 2003, 1606(1-3), 1-21.
77. Garlid, K.D.; Paucek, P.; Yarov-Yarovoy, V.; Murray, H.N.; Darbenzio, R.B.; D'Alonzo, A.J.; Lodge, N.J.; Smith, M.A.; Grover, G.J. Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels. Possible mechanism of cardioprotection. Circ. Res., 1997, 81(6), 1072-82.
78. Murphy, E. Primary and secondary signaling pathways in early preconditioning that converge on the mitochondria to produce cardioprotection. Circ. Res., 2004, 94(1), 7-16.
79. Murphy, E.; Aiton, J.F.; Horres, C.R.; Lieberman M. Calcium elevation in cultured heart cells: its role in cell injury. Am. J. Physiol., 1983, 245(5 Pt 1), C316-21.
80. Heinlein, C.A.; Chang, C. The roles of androgen receptors and androgen-binding proteins in nongenomic androgen actions. Mol. Endocrinol. 2002, 16(10), 2181-7.
81. Liu, P.Y.; Death, A.K.; Handelsman, D.J. Androgens and cardiovascular disease. Endocr. Rev., 2003, 24(3), 313-40.
82. Murry, C.E.; Jennings, R.B.; Reimer, K.A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation, 1986, 74, 1124-1136.
83. Song, X.; Li, G.; Vaage, J and Valen, G. Effects of sex, gonadectomy, and oestrogen substitution on ischaemic preconditioning and ischaemia-reperfusion injury in mice. Acta. Physiol. Scand., 2003, 177, 459-466.
84. Wu, S.; Li, H.Y and Wong, T.M. Cardioprotection of preconditioning by metabolic inhibition in the rat ventricular myocyte. Involvement of kappa-opioid receptor. Circ. Res., 1999, 84, 1388-1395.
85. Zhou, J.J.; Pei, J.M.; Wang, G.Y.; Wu, S.; Wang, W.P.; Cho, C.H and Wong, T.M. Inducible HSP70 mediates delayed cardioprotection via U-50488H pretreatment in rat ventricular myocytes. Am. J. Physiol. Heart Circ. Physiol., 2001, 281, H40-47.
86. Currie, R.W.; Karmazyn, M.; Kloc, M and Mailer, K. Heat-shock response is associated with enhanced postischemic ventricular recovery. Circ. Res., 1988, 63, 543-549.
87. Locke, M.; Tanguay, R.M.; Klabunde, R.E and Ianuzzo, C.D. Enhanced postischemic myocardial recovery following exercise induction of HSP 72. Am. J. Physiol., 1995, 269, H320-325.
88. Locke, M and Tanguay, R.M. Diminished heat shock response in the aged myocardium. Cell Stress Chaperones 1996, 1, 251-260.
89. Meng, X.; Brown, J.M.; Ao, L.; Banerjee, A and Harken, A.H. Norepinephrine induces cardiac heat shock protein 70 and delayed cardioprotection in the rat through alpha1-adrenoceptors. Cardiovasc. Res., 1996, 32, 374-383.
90. Marber, M.S.; Latchman, D.S.; Walker, J.M and Yellon, D.M. Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction. Circulation, 1993, 88, 1264-1272.
91. Pirkkala, L.; Nykanen, P and Sistonen, L. Roles of the heat shock transcription factors in regulation of the heat shock response and beyond. FASEB J., 2001, 15, 1118-1131.
92. Buerke, M.; Murohara, T.; Skurk, C.; Nuss, C.; Tomaselli, K.; Lefer, A.M. Cardioprotective effect of insulin-like growth factor I in myocardial ischemia followed by reperfusion. Proc. Natl. Acad. Sci. USA, 1995, 92(17), 8031-5.
93. Wolfman, J.C.; Palmby, T.; Der, C.J.; Wolfman, A. Cellular N-Ras promotes cell survival by downregulation of Jun N-terminal protein kinase and p38. Mol. Cell Biol., 2002, 22(5), 1589-606.
94. Yue, P.; Chatterjee, K.; Beale, C.; Poole-Wilson, P.A.; Collins, P. Testosterone relaxes rabbit coronary arteries and aorta. Circulation, 1995, 91(4), 1154-60.
95. Costarella, C.E.; Stallone, J.N.; Rutecki, G.W.; Whittier, F.C. Testosterone causes direct relaxation of rat thoracic aorta. J. Pharmacol. Exp. Ther., 1996, 277, 34-39.
96. 2+ entry mechanisms of arterial vasoconstriction by sex hormones. Clin. Exp. Pharmacol. Physiol., 1999, 26, 707-715.
97. Crews, J.K.; Khalil, R.A. Antagonistic effects of 17β-estradiol, progesterone, and testosterone on Ca2+ entry mechanisms of coronary vasoconstriction. Arterioscler. Thromb Vasc. Biol., 1999, 19, 1034-1040.
98. Perusquia, M.; Villalon, C.M. Possible role of Ca2+ channels in the vasodilating effect of 5β-dihydrotestosterone in rat aorta. Eur. J. Pharmacol., 1999, 371, 169-178.
99. Ding, A.O.; Stallone, J.N. Testosterone-induced relaxation of rat thoracic aorta involves vascular smooth muscle K1 channel activation (Abstract). FASEB J., 1996, 10, A706.
100. Ding, A.O.; Stallone, J.N. Testosterone-induced relaxation of rat thoracic aorta: structural specificity of androgen analog effects on vascular smooth muscle and endothelium (Abstract). FASEB J., 1997, 11, A264.
101. Ding, A.Q.; Stallone, J.N. Testosterone-induced relaxation of rat aorta is androgen structure specific and involves K+ channel activation. J. Appl. Physiol., 2001, 91, 2742-2750.
102. Tep-areenan, P.; Kendall, D.A.; Randall, M.D. Testosterone-induced vasorelaxation in the rat mesenteric arterial bed is mediated predominantly via potassium channels. Br. J. Pharmacol., 2002, 135, 735-740.
103. Jones, R.D.; Malkin, C.J.; Channer, K.S.; Jones, T.H. Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: further supportive data. J. Clin. Endocrinol. Metab., 2003, 88(3), 1403-4.
104. Jones, R.D.; Pugh, P.J.; Jones, T.H.; Channer, K.S. The vasodilatory action of testosterone: a potassium-channel opening or a calcium antagonistic action? Br. J. Pharmacol., 2003, 138(5), 733-44.
105. Jones, R.D.; Pugh, P.J.; Hall, J.; Channer, K.S.; Jones, T.H. Altered circulating hormone levels, endothelial function and vascular reactivity inthetesticular feminisedmouse. Eur. J.Endocrinol., 2003, 148, 111-120.
106. Deenadayalu, V.P.; White, R.E.; Stallone, J.N.; Gao, X.; Garcia, A.J. Testosterone relaxes coronary arteries by opening the large-conductance, calcium-activated potassium channel. Am. J. Physiol. Heart Circ. Physiol., 2001, 281, H1720-H1727.
107. Schror, K.; Morinelli, T.A.; Masuda, A.; Matsuda, K.; Mathur, R.S.; Halushka, P.V. Testosterone treatment enhances thromboxane A2 mimetic induced coronary artery vasoconstriction in guinea pigs. Eur. J. Clin. Invest., 1994, 24(Suppl 1), 50-52.
108. Farrukh, I.S.; Peng, W.; Orlinska, U.; Hoidal, J.R. Effect of dehydroepiandrosterone on hypoxic pulmonary vasoconstriction: a Ca2+-activated K+-channel opener. Am. J. Physiol., 1998, 274, L186-L195.
109. Molinari, C.; Battaglia, A.; Grossini, E.; Mary, D.A.; Vassanelli, C.; Vacca, G. The effect of testosterone on regional blood flow in prepubertal anaesthetized pigs. J. Physiol., 2002, 543, 365-372.
110. Chou, T.M.; Sudhir, K.; Hutchison, S.J.; Ko, E.; Amidon, T.M.; Collins, P.; Chatterjee, K. Testosterone induces dilation of canine coronary conductance and resistance arteries in vivo. Circulation, 1996, 94(10), 2614-9.
111. Hall, J.; Jones, R.D.; Jones, T.H.; Channer, K.S.; Peers, C. Selective inhibition of L-type Ca2+ channels in A7r5 cells by physiological levels of testosterone. Endocrinology, 2006, 147(6), 2675-80.